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The T cell antigen receptor (TCR)' expressed on most T lymphocytes is an
^-90 kD disulfide-linked heterodimer, composed of a and Q glycoprotein subunits.
The al,# TCR heterodimer is noncovalently associated with CD3, a glycoprotein
complex containing three or more invariant proteins (1-6, reviewed in references
7, 8). The TCR is responsible for specific antigen recognition; whereas the
invariant CD3 complex has been implicated in signal transduction (7, 8). Like
immunoglobulin genes, the genes encoding TCR-a and -,Q chains are composed
of variable (V), joining (J), and constant (C) genetic elements that undergo
rearrangement during T cell differentiation (9-12; reviewed in reference 13).
Several mAbs have been generated against the invariant CD3 proteins and
against idiotypic determinants of the TCR. One mAb, WT31, reacts with a
framework determinant present on all af# TCR heterodimers (14, 15). Using
mAbs or probes for the TCR-a and -a gene products, it has been established
that most mature T lymphocytes in vivo and most in vitro-cultured T cell lines
express antigen receptors using the a/a heterodimer (reviewed in references 7,
8, 13).
In addition to a and fl, a third gene, y, has been shown to rearrange in T
lymphocytes (16-21). y genes are also composed of V, J, and C genetic elements
(16, 19, 21). y genes are rearranged and transcribed before ,Q and a genes during
T cell ontogeny and differentiation (22-24). Recently, T lymphocytes expressing
y mRNA, but not a mRNA, have been identified (25-27). PEER, a T leukemia
cell line, expresses a non-disulfide-linked -55-60 kD glycoprotein that is non-
covalently associated with the CD3 complex on the plasma membrane (25). Lack
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of a mRNA, the presence of apparently functional y mRNA, and reactivity of
the CD3-associated ^-55-60 kD glycoprotein with an anti--y peptide antiserum
clearly indicate that the antigen receptor complex on PEER uses y, rather than
a or 0 gene products (28) . IL-2-dependent T cell lines established from patients
with immunodeficiency diseases (26) and CD4-,CD8- thymocytes (27) also ex-
press CD3-associated, non-disulfide-linked glycoproteins of -55 and -40 kD on
the cell surface . Like the PEER cell line, these IL-2-dependent cell lines tran-
scribed y mRNA, but not a mRNA, and antiserum against y peptides reacted
with the CD3-associated ^-55 kD structure (26, 27). All of these cell lines reacted
with antibodies against CD3, but did not react with WT31, an mAb directed
against the a/(3 TCR heterodimer (25-27) .
The existence ofCD3+ , WT31 - (TCR-a/0-) cell lines prompted us to examine
whether T lymphocytes with this phenotype were present in peripheral blood
and thymus obtained from normal individuals . CD3'',WT31 - T lymphocytes
were present at low frequency in peripheral blood (^"3% of PBL/T cells) and
thymus (-0.5% of thymocytes) (29) . Surprisingly, essentially all CD3',WT31-
PBL/T cells and thymocytes expressed neither the CD4 nor CD8 T cell differ-
entiation antigens (29) . In contrast, all CD3'',WT31' T lymphocytes and thy-
mocytes expressed CD4 and/or CD8 (29) . In previous studies (30), we established
IL-2-dependent T cell lines from CD3''',4-,8- PBL/T lymphocytes which stably
maintained this phenotype in culture . These IL-2-dependent CD3',4- ,8-T cell
lines are functionally competent and mediate non-MHC-restricted cytotoxicity
against a variety of NK-sensitive and NK-insensitive tumor cell targets (30) . In
the present study, we demonstrate that these CD3',4-,8- T cell lines established
from the peripheral blood of normal, healthy adult donors do not express a/a
TCR, but instead express disulfide-linked antigen receptors using y gene-
encoded proteins .
Materials and Methods
Monoclonal Antibodies . Leu series mAbs were produced by the Becton Dickinson
Monoclonal Center, Inc . (Mountain View, CA). The CD3, CD4, CD5, and CD8 differ-
entiation antigens were detected by using anti-Leu-4, anti-Leu-3, anti-Leu-1, and anti-
Leu-2 mAbs, respectively (31) . The WT31 mAb, directed against the TCR-a/0 hetero-
dimer, was generously provided by Dr . Wil Tax, University of Nijmegen,TheNetherlands
(14, 15) . An mAb against a framework determinant of the TCR 0 chain (0171) was
generously provided by Dr . Mike Brenner, Dana-Farber Cancer Institute, Boston, MA
(26) .
Immunofuorescence and Flow Cytometry.
￿
Methods of immunofluorescence, flow cytom-
etry, and data analysis have been described previously (32) . Fluorochrome-conjugated,
isotype-matched Ig that do not react with human leukocytes were used to control for
nonspecific binding in the immunofluorescence assays . Fluorescence was measured by
using a FACS 440 or FACStar flow cytometer and data were analyzed by using a Consort
30 or Consort 40 Data Analysis System (Becton Dickinson Immunocytometry Systems,
Mountain View, CA) .
Isolation and Culture ofPeripheral Blood CD3+,4-,8- T Lymphocytes .
￿
Mononuclear cells
from normal peripheral blood (Stanford Blood Center, Stanford, CA) were isolated using
Ficoll/Hypaque . Monocytes were depleted by plastic adherence . Nonadherent cells were
stained with a mixture of FITC-conjugated anti-Leu-2 (CD8), FITC-conjugated anti-Leu-
3 (CD4), and phycoerythrin (PE)-conjugated anti-Leu-4 (CD3) . After extensive washing
in ice-cold PBS(0.01 M phosphate, pH 7.2), the cells were resuspended in PBS containing
1% FCS . Lymphocytes expressing CD3, but lacking both CD4 and CD8, therefore
demonstrated specific red (PE) fluorescence, but not green (FITC) fluorescence .1078
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CD3',4-,8- cells were isolated to >95% purity by cell sorting using a FACS. Cells were
cultured in RPMI 1640 supplemented with 10% FCS (KC Biologicals, Lexena, KS), 1
mM glutamine, 100 kg/ml gentamicin, and 1,000 U/ml rIL-2 (Cetus Corp., Emeryville,
CA).
Mitogenic Stimulation.
￿
PBMC were cultured at 106 cells/ml in RPMI 1640 medium
supplemented with 10% FCS, 1 mM glutamine, 100 Pg/ml gentamicin, and 2 gg/ml PRA-
M (Gibco Laboratories, Grand Island, NY). Cells were harvested after 3 d and washed
extensively in PBS.
Cell Lines.
￿
The HPB-ALL T leukemia cell line was generously provided by Dr. J.
Minowada (Fujisaki Cell Center, Okayama, Japan), the HUT 78 T leukemia cell line was
obtained from the American Type Culture Collection (Rockville, MD), and the DAUDI
B cell line was obtained from the NIGMS Human Genetic Mutant Cell Repository
(Camden, NJ). The cloned, IL-2-dependent NK cell line, NKIA3, was generously pro-
vided by Drs. B. Gemlo and A. Rayner, University ofCalifornia, Los Angeles, CA.
Immunoprecipitation and SDS-PAGE Analysis.
￿
Cells were labeled with "'I (Amersham
Corp., Arlin ton Heights, IL) by using the glucose oxidase/lactoperoxidase method (33).
1-5 x 106 "El-labeled cells were washed three times in 1 ml PBS containing 10 mM
iodoacetamide, and were lysed in 0.5 ml lysis buffer (0.05 M Tris-HCl, 0.15 M NaCl,
0.02% NaN3, pH 8.0) containing 20 KI units/ml aprotinin (Sigma Chemical Co., St.
Louis, MO), 10 mM iodoacetamide, and 5 mM Chaps (3[3-cholamidopropyl-dimethylam-
monio]-I-propane sulfonate) (Calbiochem-Behring Corp., San Diego, CA)) for 45 min at
4 0C. Cells were pelleted by centrifugation at 13,000g for 5 min. For removal of unbound
1251, the lysates were passed through a 0.2 ml (bed volume) column of Dowex IX8-400
(chloride form; Sigma Chemical Co.), equilibrated in lysis buffer. After this procedure,
>85% of the radioisotope present in the lysate was precipitated by 10% TCA. Before
specific immunoprecipitation, lysates were precleared twice by incubation with 10 mg of
packed formalin-fixed Staphylococcus aureus (Pansorbin; Calbiochem-Behring Corp.)
coated with rabbit anti-mouse IgG (Pel-Freeze Biologicals, Rogers, AR). For specific
immunoprecipitation, 50 A1 S. aureus (Pansorbin, 10% wt/vol solution) were incubated
for 15 min at 4°C with saturating amounts of rabbit anti-mouse IgG antiserum, washed
twice in lysis buffer by centrifugation at 13,000 g for 15 s, then incubated for 1-2 h with
1-5 Rg of specific mAb in a total volume of 100 u1 of lysis buffer. mAb-coated S. aureus
were washed once in lysis buffer, then 50-100 Xl of "'I-labeled cell lysate was added to
the mAb-coated S. aureus pellet. After 2 h ofincubation at 4°C, the S. aureus were washed
five times in lysis buffer containing 0.5 M NaCl. Bound material was eluted by boiling in
sample buffer containing 2.3% SDS with or without 5% 2-ME (34). Samples were analyzed
by SDS-PAGE using a discontinuous buffer system (34). Two-dimensional gel electropho-
resis, using nonequilibrium pH gradient electrophoresis (NEPHGE) in the first dimension
and SDS-PAGE using 10% acrylamide gels in the second dimension, was performed as
described by Jones (35). pH 3.5-10 ampholines (LKB Instruments Inc., Gaithersburg,
MD) were used in NEPHGE analysis. Two-dimensional diagonal gel electrophoresis, using
SDS-PAGE under nonreducing conditions in the first dimension, followed by SDS-PAGE
under reducing conditions in the second dimension, was performed as described (1).
Protein standards (reducing: Sigma Chemical Co. ; nonreducing, Pharmacia Fine Chemi-
cals, Piscataway, NJ) were included for molecular weight determination. Gels were dryed
and autoradiographed at -70°C on Kodak XR film using intensifying screens (Cronex
Lightening Plus; DuPont Co., Wilmington, DE).
Anti--y Antiserum.
￿
A peptide corresponding to the predicted amino acid sequence of
C,yl derived from nucleotides 237-281 was synthesized using a solid-phase peptide
synthesizer (Peninsula Laboratories, Inc., Belmont, CA) (36). The peptide was purified
by HPLC and coupled to KLH at a ratio of 5 mg:l mg (carrier/peptide). Rabbits were
immunized subcutaneously with 100 rug of specific peptide conjugate emulsified in CFA
and boosted twice at 3-wk intervals before bleeding. Specific reactivity of the antipeptide
antiserum was demonstrated in an enzyme-linked immunoassay.
Immunoprecipitation of .y Chain.
￿
The CD3/TCR complex was immunoprecipitated
from Chaps detergent lysates of .2.I-labeled cells using formalin-fixed S. aureus coated
with anti-Leu-4 mAb (as described above). The CD3/TCR complex was eluted from theLANIER ET AL.
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immunoabsorbent by incubation for 30 min at 56°C in 100 Al of lysis buffer containing
1 % SDS and 2mM DTT (26) . Samples were alkylated and partially renatured by dilution
in four volumes of Tris-buffered saline (0 .05 M Tris, 0.15 M NaCl, pH 7.4) containing
1 .5% NP-40 detergent and 20 mM iodoacetamide . Samples were subsequently divided
into aliquots and incubated with 50 ul formalin-fixed S. aureus (Pansorbin ; 10% vol/vol
solution) precoated with either 10 Fcl rabbit anti-Cy peptide serum or normal rabbit serum .
After incubation for 2 h at 4°C, the immunoabsorbent was washed in lysis buffer . Bound
material was eluted in sample buffer containing 2.3% SDS and 5% 2-ME. Samples were
analyzed bySDS-PAGE using 10% acrylamide gels .
Probes .
￿
A murine ,B cDNA probe (TM86T5) (37) and a murine Ca probe (38) were
generously provided by Dr . M . Davis (Stanford University, Stanford, CA) and Dr. L .
Hood (Cal Tech, Pasadena, CA), respectively . A human genomic Jy probe (pH60) (18)
was generously provided by Dr . T . Rabbitts (Medical Research Council, Cambridge,
United Kingdom) . A murine y cDNA probe (8A2) was isolated from a cDNA library
constructed from a C57BL/6 murine T leukemia cell line, C6VL (1), and was subdoned
intopUC8 . A 0.6-kb Pvu II/Ava I insert, corresponding to a J-C region segment of the 7
gene (nucleotides 444-1,028 in the 7 cDNA sequence [16]) was isolated and was used as
probe for Northern blot analysis .
Southern and Northern Blot Analysis .
￿
Cells were washed with PBS and pelleted in a
microfuge tube . Cytoplasmic RNA was isolated as described by Favaloro et al . (39), with
minor modifications . Nuclei were pelleted and used for subsequent genomic DNA puri-
fication according to the method of Law et al . (40), with the addition of 40 'Ul 5%
Sarkosyl/0.5 M EDTA to the usual lysis buffer to ensure complete lysis . Genomic DNA
was digested with restriction enzymes (New England Biolabs, Beverly, MA) and was
electrophoresed in 0.8% agarose gels (41) . After electrophoresis, the gels were stained
with ethidium bromide to verify the integrity ofthe DNA and to confirm that comparable
amounts of DNA were present in all lanes . RNA was electrophoresed in 1 .0% agarose
gels (41) . RNA and DNA were transferred to nitrocellulose membranes (Bio-Rad Labo-
ratories, Richmond, CA) and baked for 2 h in a vacuum oven at 80°C (41) . Probe inserts
were isolated and were labeled with ["P]dCTP (Amersham Corp .) (>10 9 cpm/,Ug DNA)
by the method of Feinberg and Vogelstein (42) . Membranes were hybridized at 65°C
for 24 h with ^-2 x 10 7 cpm of ["P]dCTP-labeled probe in 35 ml hybridization buffer
(5x SSPE [1X SSPE : 0.15 NaCl, 10 mM NaH2PO4-H2O, 1mM EDTA, pH 7.4], 1x
Denhardt's, 0.3% SDS, 10% dextran sulfate, and 100 ag/ml denatured salmon sperm
DNA). After hybridization, membranes were washed twice for 15 min and twice for 30
min (room temperature) in 10 mM sodium phosphate, 1 mM disodium EDTA, and 0.2%
SDS . After a final wash for 45 min at 65°C, the membranes were autoradiographed .
Fragment sizes were determined based on standards purchased from Bethesda Research
Laboratories (Bethesda, MD) .
Results and Discussion
IL-2-dependent CD3+,4-,8' Cell Lines Lack Reactivity with WT31 mAb .
￿
^-3% of
normal peripheral blood CD3+ T lymphocytes express neither CD4 nor CD8
differentiation antigens (30) . CD3'',4-,8- peripheral blood T lymphocytes were
isolated to >95% purity and were established in culture using HL-2 as growth
factor (30) . CD3+,4-,8- T cell lines have been established from >15 normal
donors, and>90% oflymphocytes stably maintained the phenotype, CD3*,4-,8- .
To characterize the TCR, IL-2-dependent CD3 +,4-,8- cell lines derived from
15 independent donors were stained with WT31, an mAb directed against the
TCR-a/# heterodimer. None of these CD3+,4-,8- cell lines reacted with WT31,
although all cell lines reacted with anti-Leu-4, an mAb directed against CD3 .
Data from a representative CD3'',4-,8- cell line is presented in Fig . 1 . As noted
previously (30), a small fraction of cells within these IL-2-dependent CD3+,4-,8 -
cell lines expressed very low levels ofCD8 antigen (approximately one-tenth the1080
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FIGURE 1 . IL-2-dependent pe-
ripheral blood CD3*,4-,8- T cell
lines lack reactivity with antibody
WT31 (anti-TCR-a/,B) . IL-2-de-
pendent CD3`,4- ,8- peripheral
blood T cell lines were stained
with: (A) FITC-conjugated IgG
and PE-conjugated IgG control
mAb ; (B) FITC-conjugated
WT31 and PE-conjugated anti-
Leu-4 (CD3) ; (C) FITC-conju-
gated anti-Leu-2 (CD8) plus
FITC-conjugated anti-Leu-3
(CD4) and PE-conjugated WT31 ;
and (D) FITC-conjugated anti-
Leu-2 (CD8) and PE-conjugated
anti-Leu-3 (CD4) . Samples were
analyzed by flow cytometry . Cor-
related green (FITC: abscissa,
four decade scale) and red (PE :
ordinate, four decade scale) fluo-
rescence were displayed as con-
tour plots . Based on the control
sample, contour plots were di-
vided into quadrants to represent
unstained cells (lower left), cells
stained only with PE (upper left),
cells stained only with FITC
(lower right), and cells stained with
both FITC and PE (upper right) .
amount of CD8 antigen expressed on most peripheral blood T lymphocytes) .
However, as shown in Fig . 1, even these dim CD8+ cells failed to react with
WT31 . We suspect that these dim CD8' lymphocytes were generated from the
CD3+ ,4-,8- population as a consequence of in vitro culture ; however, we cannot
exclude the possibility that these cells were a contaminant in the isolation of
peripheral blood CD3+ ,4-,8` lymphocytes . CD4+ cells were never detected in
these cell lines. These results are consistent with our recent studies (29) demon-
strating that WT31 mAb fails to react with the ^r3% of normal peripheral blood
CD3+T lymphocytes that coexpress neither CD4 norCD8. Hence, thesecultured
cell lines appear to be derived from and representative of theCD3+,4-,8" normal
PBL/T cell subset .
Biochemical Characterization of the CD3-associated Proteins Expressed on CD3+,
4-,8 - (WT31 -) T Cell Lines . Prior studies have demonstrated that the TCR-a/(3
heterodimer is noncovalently associated with the CD3 glycoprotein complex (1-
8) . Using certain detergent systems, e .g ., Chaps (25) and digitonin (43), it has
been possible to preserve this association and coimmunoprecipitate the intact
CD3/TCR complex using antibodies either against CD3 or TCR. This technique
was used to identify the CD3-associated structures expressed on IL-2-dependent
CD3+,4-,8- cell lines . CD3+,4-,8` cells (>95% WT31-) were radiolabeled with
'251, solubilized in Chaps detergent lysis buffer, and immunoprecipitated with
anti-Leu-4 (CD3)mAb. Immune complexes were analyzed by SDS-PAGE . IL-2-
dependent CD3+,4- ,8- (WT31-) cell lines established from five independent
normal individuals were assayed . Representative data from two cell lines are
shown in Fig . 2 . A disulfide-linked structure of ^"90 kD was coimmunoprecipi-LANIER ET AL .
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FIGURE 2 . Immunoprecipitation and SDS-PAGE analysis of the CD3/TCR complex ex-
pressed on CD3+,4-,8-T cell lines . IL-2-dependent CD3+,4-,8- cell lines from two different
donors (No . I, lanes 1-6 ; and No . 2, lanes 7, 8, 11, 12) and normal peripheral blood T
lymphocytes (PBL-T; lanes 9, 10, 13, 14) were radiolabeled with 1251 and were detergent
solubilized . Both CD3+,4-,8- cell lines were>95% WT3I- ; whereas normal PBL-T cells were
-97% WT31+ , as determined by flow cytometry . Lysates were immunoprecipitated using S .
aureus coated with control Ig (lanes 1, 4, 7, 11, and 13), anti-Leu-4 (CD3) (lanes 2, 5, 8, 10,
12, and 14), or anti-Leu-1 (CD5) (lanes 3 and 6) . Immune complexes were eluted from S .
aureus in sample buffer containing 2.3% SDS, either with or without 5% 2-ME . Immunopre-
cipitates were analyzed using 12.5% (A) or 10% (B) acrylamide gels. Note that the -38-kD
band seen in lane 2has notbeen consistently observed and may be the result of partial sample
reduction in this experiment.
tated with the CD3 complex (22-29 kD). Under reducing conditions, the 90-kD
structure dissociated into three subunits of -45, ^-40, and ^"37 kD . The CD3-
associated -90 kD heterodimer expressed on two of the five CD3+,4- ,8-
(WT31-) cell lines examined dissociated into only two subunits of -45 and ^"40
kD upon reduction (not shown) . These structures were not coimmunoprecipi-
tated with anti-Leu-1 (CD5) or control mAb (Fig. 2A). Furthermore, these CD3-
associated structures were not coimmunoprecipitated with anti-Leu-4 in deter-
gent systems (e.g ., NP-40) that dissociated the CD3/TCR complex (not shown) .
Immunoprecipitation of the CD3/TCR-a/0 heterodimer complex from normal
PBL/T cells (^-97% WT3I') is shown for comparison (Fig . 2B) . Normal PBL/T
lymphocytes demonstrated an ^-95 kD heterodimer (nonreduced) that dissociated
into diffuse bands of ^-47 and ^-40 kD upon reduction .
Two-dimensional "diagonal" gel electrophoresis was used to determine the
relationship of the ^-45, ^"40, and ^-37 kD (reduced) subunits to the single ^-90
kD (nonreduced) structure . Anti-Leu-4 (CD3) immunoprecipitates were sepa-
rated by SDS-PAGE under nonreducing conditions in the first dimension,
followed by reduction and separation by SDS-PAGE under reducing conditions
in the second dimension. Using this technique, structures with interchain disul-
fide bonds were dissociated in the second dimension, and thus were observed
below the diagonal ; whereas, non-disulfide-linked structures were observed on1082
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FIGURE 3 .
￿
Diagonal gel electrophoresis analysis of the CD3/TCR complex expressed on
CD3',4-,8- T cells. Detergent-solubilized lysates of "'I-labeled IL-2-dependent CD3',4- ,8-
(WT31-) cells (same sample as lane 2 in Fig . 2) (A), normal PBL-T cells (B), and the HPB-ALL
tumor cells (C) were immunoprecipitated with anti-Leu-4 (CD3) . Samples were analyzed by
two-dimensional gel electrophoresis (Ist dimension, SDS-PAGE nonreducing; 2nd dimension,
SDS-PAGE reducing) using 10% acrylamide gels . As noted in Fig . 2, the minor band above
the diagonal probably represents heterodimer that was partially reduced during preparation,
since the mobility of this protein is essentially identical to the ^-45 kD subunit below the
diagonal .
the diagonal . As shown in Fig . 3A, all three ^-45, ^-40, and ^-37 kD subunits
were predominately observed directly below the diagonal, indicating that the
^-90 kD (nonreduced) structure is composed primarily ofdisulfide-linked dimeric
pairs of these subunits . Careful examination of the relative mobility of these
subunits suggested that these proteins may form dimers composed of ^-45/^-40
kD and ^-45/^37 kD ; however, further studies will be necessary to confirm this
notion . Since the CD3',4- ,8- cell lines used in the present experiments were not
cloned, this observation may reflect heterogeneity within the cell population .
Thus, we cannot exclude the alternative possibility that these subunits assemble
as homodimers, rather than heterodimers . Diagonal gel electrophoresis of the
CD3/TCR complex immunoprecipitated from HPB-ALL tumor cellsand normalLANIER ET AL .
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PBL/T lymphocytes are shown for comparison (Fig . 3, B and C) . Prior studies
have established that HPB-ALL cells express a CD3-associated heterodimer
composed of a and 0 subunits that reacts with the WT31 mAb (15, 44) .
The CD3/TCR complex expressed on CD3'',4-,8- cells was further analyzed
by two-dimensional electrophoresis using pH-dependent separation in the first
dimension, followed by size separation in the second dimension . NEPHGE
analysis revealed that the -37 and ^-40 kD subunits migrated with essentially
identical mobility, whereas the ^-45 kD structure was substantially more basic
(Fig . 4) . It is possible that the -37 and -40 kD subunits are differentially
glycosylated species of the same protein . The -45 kD subunit appears to be a
distinct polypeptide, unrelated to the -37 and -40 kD subunits. Further studies
support this notion (see below) . It should be noted that no a-like acidic subunits
were observed in the CD3/TCR complex isolated from CD3+,4',8- cells . In
contrast, NEPHGE analysis of the CD3/TCR structure expressed on HPB-ALL
demonstrated a relatively acidic subunit of ^-45 kD (the a chain) and a relatively
basic subunit of -37 kD (the # chain) .
Reactivity of the CD3-associated Heterodimer with Anti--y Antiserum, But not Anti-
,Q Framework mAbs. Detergent (Chaps) lysates of 125I-labeled CD3',4-,8- cell
lines and HPB-ALL tumor cells were incubated with S . aureus coated with ,6F1
mAb . Brenner et al . (26)have previously demonstrated thatOF I mAb specifically
reacts with a framework determinant on the TCR ,B chain . Furthermore, it has
been shown that anti-#F1 mAb reacts with >95% ofnormal PBL-T lymphocytes,
by immunofluorescent cytoplasmic staining techniques (26) . As shown in Fig . 5,
anti-Leu-4 (CD3) mAb immunoprecipitated a CD3-associated heterodimer from
both HPB-ALL cells and the CD3+,4-,8- cell line . However, whereas OF 1 clearly
reacted with the heterodimer present on HPB-ALL tumor cells, this antibody
did not react with the CD3-associated heterodimer expressed on the CD3+,4-,8-
cell line .
The CD3-associated heterodimer expressed on CD3+,4-,8- cells did react with
an antiserum directed against a synthetic Cy-chain peptide . The CD3/TCR
heterodimer immunoprecipitated from CD3',4-,8- cells was eluted from anti-
Leu-4 (CD3) immunoadsorbent . After denaturation and reduction, samples were
renatured and alkylated . These proteins were reprecipitated with anti-Cy peptide
serum, or normal rabbit serum . As shown in Fig . 6, anti-Cy peptide serum
specifically reacted with the -37 and ^-40 kD CD3-associated subunits, but not
with the CD3 polypeptides or the -45 kD subunit . Anti-Cy peptide serum failed
to react with either the a chain or (3 chain of the heterodimer expressed on HPB-
ALL orJURKAT tumor cells (not shown) . These results suggest that the ^" 37
and -40 kD subunits expressed on CD3',4-,8` cells are y chain-encoded
proteins . The nature of the higher molecular mass ^-45-kD subunit is unknown .
However, the possibility that this polypeptide is a fl chain product was excluded
by the observation that #F I mAb failed to react with this structure .
Transcription of TCR Genes in CD3+,4-,8- (WT31-) Cell Lines.
￿
To further
characterize these CD3'',4-,8- (WT31-) cell lines, RNAwas isolatedand analyzed
by Northern blot analysis for the presence of a, ,B, and y transcripts . As shown
in Fig . 7, CD3+,4-,8- (WT31 -) cells contained abundant 'Y gene transcripts of
^-1 .6 kb . In contrast, we failed to detect a significant amount of full-length 1 .3-
kD 0 mRNA, although small amounts of 1 .0-kb 0 (presumably nonfunctional)1084
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FIGURE 4 .
￿
NEPHGE analysis of the CD3/TCR complex expressed on CD3',4-,8- T cells.
Detergent solubilized lysates of 12'1-labeled IL-2-dependent CD3',4-,8-(WT31 -) cells (A)and
the HPB-ALL tumor cells (B) cells were immunoprecipitated with anti-Leu-4 (CD3) . Samples
were analyzed by NEPHGE . 10% acrylamide gels were used for SDS-PAGE analysis in the
2nddimension .
mRNA were detected . Similarly, only very low amounts of 1 .6-kb amRNA were
detected in the CD3+,4-,8 - cell line . We cannot exclude the possibility that this
small amount ofa mRNA was transcribed by a minor population of contaminat-
ing CD3',WT3I' T lymphocytes (composing 2-5% of these cell lines) . A 1.1-kb
a transcript was also observed ; the significance of this short a transcript isLANIER ET AL.
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FIGURE 5 .
￿
Immunoprecipitation with anti-!B chainmAb. Detergent solubilized lysates of
121I_
labeled IL-2-dependent CD3*,4-,8- (WT31- ) cells and HPB-ALL tumor cells were immuno-
precipitated with : control Ig (C), ,BFI, and anti-Leu-4 (CD3), as indicated . Immune complexes
were eluted from S. aureus in sample buffer containing 2.3% SDS, either with or without 5%
2-ME . Samples were analyzed by SDS-PAGE using 10% acrylamide gels .
unknown . As controls, mRNA from PHA-activated peripheral bloodT lympho-
blasts from normal donors andHPB-ALLT leukemia tumor cells were analyzed .
PHA T lymphoblasts and HPB-ALL cells that reacted with WT31 mAb ex-
pressed apparently competent 1.3-kb fl and 1.6-kb a mRNA . y mRNA was not
detected in PHA-activated T lymphoblasts . Although y mRNA was detected in
HPB-ALLtumor cells, there is no evidence that this transcript encodesfunctional
protein .
Rearrangement ofTCR Genes in CD3+,4-,8- (WT31) Cell Lines.
￿
In humans,
two Cy genes, each with associated J elements, have been identified (18, 19) .
Rearrangement of y genes is readily detected by Southern blot analysis using J
region probes (18, 19) . Genomic DNA from CD3'',4-,8- (WT31-) cells was
isolated, digested with Eco RI restriction enzyme, and assayed by Southern blot
analysis using aJy probe . DNA isolated from clonedT leukemia cell lines (HPB-
ALL and HUT 78) contained rearranged fragments consistent with monoclonal
cell populations. Only unrearranged, germline fragments were detected in a B1086
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FIGURE 6 .
￿
Immunoprecipitation with anti-y antiserum . Detergent-solubilized lysates of '25I-
labeled IL-2-dependent CD3+,4-,8- (WT31-) cells (same cell line as used in Fig . 5) were
immunoprecipitated with anti-Leu-4 (CD3) . Immune complexes were eluted from S . aureus
and reimmunoprecipitated using rabbit anti-y peptideserumor normal rabbit serum (control)
as described in MaterialsandMethods . Sampleswere analyzed by SDS-PAGE (A)andNEPHGE
(B) using 10% acrylamide gels.
cell line (DAUDI). y geneswere rearranged in both CD3+,4-,8-cellsand normal
PBL/T (^-97% WT31') lymphocytes (Fig . 8) .2 The rearranged fragments seen
in the CD3',4-,8- (WT31-) cell line were similar to the rearranged fragments
seen in normal polyclonal PBL/T lymphocytes isolated from two independent
donors . These results suggest that the CD3+,4-,8- cell line is polyclonal, rather
than monoclonal . Similar results were also obtained using CD3*,4-,8- (WT31-)
cell lines established from two different donors (not shown) . DNA from
CD3+,4-,8- (WT31-) cell lines were also digested with Kpn 1, another restriction
enzyme that allows detection ofy gene rearrangement in polyclonal PBL/T cells
(45) . Polyclonal rearrangement of y genes in theCD3+,4-,8- (WT31-) cell line
was similarly observed (not shown) .
The genomic organization of ,# genes in CD3+,4-,8- (WT31-) cell lines was
also examined and compared with polyclonal PBL/T lymphocytes (Fig . 9) . DNA
from aB cell line (DAUDI)andacloned,CD3-NK cell line were not rearranged,
and served as germline controls in these experiments . Using Eco RI restriction
enzyme analysis, ^-10 and ^"3 .7 kb fragments representing germline C,#1 and
C,02 genes, respectively, were detected (46) . In germline DNA, the 10- and 3 .7-
x Although the intensity of rearranged y gene fragments varied between different blood donors,
identical fragments were observed in all PBL/T cell populations examined (45) . No polymorphism
hasbeen detected using Eco RI restriction enzyme analysis (45) .LANIER ET AL .
￿
1087
FIGURE 7 .
￿
Northern blot analysis ofTCR gene products expressed
by CD3',4-,8-T cells. RNA were isolated from an IL-2-dependent
CD3+,4-,8- (WT31-) cell line (lanes 1, 4, and 7), PHA-activated T
lymphocytes from normal donors (lanes 2, 5, and 8) and HPB-ALLT
leukemia cells (lanes 3, 6, and 9) . Equalamountsof each RNA (12 ,ug/
lane)were analyzed by the Northern blot technique, using '4P-labeled
-y (A), 0 (B), anda (C) probes . Membranes B and C were rehybridized
with 7 probe to ensure that lanes 1, 4, and 7 contained equivalent
amounts ofRNA (not shown) .
kb bands were approximately equal in intensity; whereas, rearrangement of C,81
genes resulted in a reduction of the 10-kb band (46) . Consistent with prior
reports (46, 47), normal, polyclonal PBL/T lymphocytes demonstrated extensive
rearrangement of C,Q1 genes, resulting in significant loss of the germline 10-kb
fragment . Like PBL/T lymphocytes, CD3+,4`,8- (WT31-) cell lines demon-1088
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FIGURE 8 .
￿
Southern blot analysis of y gene rear-
rangement in CD3+,4-,8- T cells . Genomic DNA
(10 ug, as determined by spectrophotometric de-
termination) from an IL-2-dependent CD3*,4-,8-
(WT31") cell line, a B cell line (DAUDI), normal
PBL/T lymphocytes from two different individu-
als, HUT 78 T leukemia cells and HPB-ALL T
leukemia cells were digested with Eco RI restric-
tion enzyme. Gels were stained with ethidium bro-
mide to verify the integrity of the DNA and to
confirm that comparable amounts of DNA were
present in all lanes . DNA were analyzed by the
Southern blot technique using '$P-labeled Jy
probe .
strated rearrangement of Cß 1 genes, as reflected by extensive loss of the 10-kb
fragment . Loss of the 10-kb fragment, withoutappearance of discrete rearranged
fragments, supports the conclusion that CD3''',4-,8- (WT31-) cell lines are
polyclonal . Restriction enzyme analysis using Bam HI (to detect Cß2 gene
rearrangements [46]), demonstrated that CD3+,4-,8- (WT31-) cell lines were
essentially identical to polyclonal PBL/T cells and did not contain clonal rear-
rangements (not shown) .
Relationship of Normal Peripheral Blood CD +,4 -,8- T Cell Lines to Other
CD3+,WT31 - Cell Lines. PEER T leukemia cells (25), IL-2-dependent
CD3+,4',8- clones established from cultured thymocytes (27), and IL-2-depend-
ent CD3+ T cell lines established from immunodeficiency patients with bare
lymphocyte syndrome and ectodermal dysplasia syndrome (26) all failed to react
with WT31 mAb. Both the thymic and immunodeficient T cell lines demon-
strated two non-disulfide-linked proteins of ^-55 and ^-40 kD that were coim-
munoprecipitated with anti-CD3 mAbs . The PEER cell line expressed an ^-55
kD glycoprotein . Although an ^-40-kD protein was not visualized by ' 251 radiol-
abeling, this does not exclude the possibility that PEER also expresses a secondLANIER ET AL .
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FIGURE 9. Southern blot analysis of /3 gene rear-
rangement in CD3*,4-,8- T cells. GenomicDNA (10
lug, as determined by spectrophotometric determina-
tion) from an IL-2-dependent CD3+,4-,8- (WT31 -)
cell line, a B cell line (DAUDI), normal PBL/T lym-
phocytes,and an IL-2-dependent CD3- NK cell clone
(NKIA3) were digested with Eco RI restriction en-
zyme . Gels were stained with ethidium bromide to
verify the integrity of the DNA and to confirm that
comparable amounts ofDNAwere present in all lanes .
DNA were analyzed by the Southern blot technique
using "P-labeled # probe.
non-disulfide-linked subunit. The non-disulfide-linked -55-kd protein ex-
pressed by the immunodeficient T cell lines (26) and PEER (28) reacted with
antiserum against 7 peptides . Similarly, the -40- and ^-37-kD subunit of the
disulfide-linked heterodimer expressed on CD3+,4-,8- cell lines established from
normal, adult peripheral blood reacted with anti-y chainantiserum . In contrast,
the ^-45-kD subunit of the disulfide-linked heterodimer failed to react with anti-
,y serum . Whetheror not this ^-45-kDsubunit ofthedisulfide-linked heterodimer
is related to the ^-40-kD subunit of the non-disulfide-linked heterodimer ob-1090
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served on immunodeficient T cell lines is unknown. Brenner and colleagues (26)
have proposed that this ^"40-kD protein may be encoded by a fourth T cell
antigen receptor gene, tentatively designated TCR-S.
The existence of non-disulfide-linked heterodimers and disulfide-linked het-
erodimers containing y chain proteins may reflect preferential use of the two
different Cy genes. Normal peripheral blood CD3',4-,8- (WT31 -) T cells may
exclusively transcribe the C-fl gene . The C71 gene has a cysteine residue
proximal to the transmembrane segment that is potentially available to form
interchain disulfide-linked dimers (28, 48). The Cy2 gene used by PEER (and
possibly the thymic and immunodeficient T cell lines) lacks this cysteine residue
proximal to the transmembrane region (28, 48). It will be ofinterest to determine
whether differential expression of Cy l and Cy2 genes will correlate with func-
tion, stage of differentiation or tissue origin of T lymphocyte expressing y chain
receptors. Preferential expression of Vy genes in murine fetal thymocytes and
mature T lymphocytes has been observed by Garman and colleagues (49).
Like CD3i',4-,8- cell lines established from adult peripheral blood, F6C7, an
IL-2-dependent CD3'',WT31 - T cell clone established from fetal blood, also
expresses an -r85-kD disulfide-linked structure associated with the CD3 complex
(50). Upon reduction of the ~85-kD structure, only an ^-44-kD subunit was
visualized, suggesting that this structure may be a homodimer (50) . F6C7 cells
transcribe apparently functional 1 .3-kb ,Q mRNA, as well as 1 .6-kb y mRNA, but
not a mRNA (50). There was no indication whether or not this homodimer is a
y gene product. However, if this disulfide-linked antigen receptor is encoded by
y, it is probably using the Cy 1 gene.
At present, there is insufficient data to explain the relationship between the
majority of T lymphocytes that express an a/,B antigen receptor versus the
infrequent subset of T lymphocytes that express a y/S receptor in association
with the CD3 complex. Moreover, the biological significance of the preferential
use of CyI and Cy2 genes to encode non-disulfide-linked versus disulfide-linked
receptors is unclear. These questions are of particular interest in relation to an
understanding of T cell ontogeny and differentiation. It has been proposed that
T lymphocytes expressing TCR-y proteins represent a developmental stage of T
cell maturation, and that immature thymocytes may express an heterodimeric
antigen receptor composed of y chain and 0 chain subunits (22, 51). By this
scenario, immature TCR-7/# T lymphocytes would progress to express a TCR-
a/,o and CD4 and/or CD8 antigens, as a consequence of differentiation, presum-
ably in the thymus. Our present data, as well as the observations of others (26,
27), have clearly demonstrated that the y chain heterodimers expressed on both
peripheral and thymic T lymphocytes do not contain (3 chain subunits. Moreover,
even in the PEER cell line, in which 0 chain protein is detected in the cytoplasm,
no y/(3 heterodimers were detected on the plasma membrane (28).
T lymphocytes expressing y chain antigen receptors are more abundant in
adult peripheral blood than in thymus, indicating that cells expressing y chain
antigen receptors do not represent a major stage of thymic development (29).
We have suggested that T cells expressing a functional CD3/antigen receptor
complex using TCR-y proteins may represent an independent lineage of T
lymphocytes, distinct from the majority of T cells expressing an a/,Q antigen
receptor (29). Additionally, since most T lymphocytes with cell surface TCR-yWe thank Drs . Mark Davis, Terry Rabbitts, Wil Tax, L. Hood, Mike Brenner, Anthony
Rayner, and Brett Gemlo for generously providing cell lines, reagents, antibodies, and
probes . We also thank Ms . Eleni Callas and Mr . Jan Keij for expert assistance with the
flow cytometry, and Mr . Robert Shields for excellent technical assistance .
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receptors express neither CD8 nor CD4 (antigens that have been implicated in
class I and class Il MHC interactions, respectively), antigen recognition by these
cells may lack restriction by theMHC. The ability to isolate and establish stable
in vitro cultures ofT cells expressing TCR-'y antigen receptors will provide the
opportunity to resolve these questions.
Summary
IL-2-dependent cell lines were established from normal peripheral bloodT
lymphocytes that express neither CD4 nor CD8 differentiation antigens .
CD3+,4-,8- cell lines from 15 different donors failed to react with WT31, an
mAb directed against theT cell antigen receptor a/,B heterodimer. Anti-Leu-4
mAb was used tp isolate the CD3/T cell antigen receptor complex from '25I-
labeled CD3+,4-,8- (WT31-)T cells . Using detergent conditions that preserved
theCD3/T cell antigen receptor complex, an -90kD disulfide-linked heterodi-
mer, composed of ^"45- and -40- (or ^-37-) kD subunits, was coimmunoprecipi-
tated with the invariant 20-29-kD CD3 complex . Analysis of these components
by nonequilibrium pH gradient electrophoresis indicated that the ^"40-kD and
^-37-kD subunits were similar, and quite distinct from the more basic ^-45-kD
subunit . None of these three subunits reacted with an antibody directed against
a 0 chain framework epitope. Heteroantiserum against aT cell receptor .y chain
peptide specifically reacted with both the ^-37- and ^-40-kD CD3-associated
proteins, but not with the ^"45-kD subunit. CD3+,4-,8- cells failed to transcribe
substantial amounts of functional 1.3-kb # or 1.6-kb a mRNA, but produced
abundant 1 .6-kb7mRNA . Southern blot analysis revealed that theseCD3+,4-,8-
cell lines rearranged both 'y and ,B genes, and indicated that the populations were
polyclonal . The expression of a CD3-associated disulfide-linked heterodimer on
CD3+,4-,8-T cell linesestablished from normal, adult peripheral blood contrasts
with prior reports describing a C133-associated non-disulfide-linked heterodimer
on CD3'/WT31- cell lines established from thymus and peripheral blood ob-
tained from patients with immunodeficiency diseases . We propose that this
discrepancy may be explained by preferential usage of the two C7 genes in T
lymphocytes .
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